{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:08:48Z","timestamp":1779109728371,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Anestesiolog\u00eda y Reanimaci\u00f3n (English Edition)"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.redare.2026.502116","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T01:16:01Z","timestamp":1777598161000},"page":"502116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Angiotensin II in the treatment of distributive shock and identification of clinical profiles with greater therapeutic benefit"],"prefix":"10.1016","volume":"73","author":[{"given":"J.","family":"Nieves-Alonso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Garc\u00eda-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Su\u00e1rez-de-la-Rica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.redare.2026.502116_bib0005","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00134-007-0531-4","article-title":"Hemodynamic monitoring in shock and implications for management: International Consensus Conference, Paris, France, 27\u201328 April 2006","volume":"33","author":"Antonelli","year":"2007","journal-title":"Intensive Care Med"},{"issue":"8","key":"10.1016\/j.redare.2026.502116_bib0010","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.redare.2026.502116_bib0015","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.redare.2026.502116_bib0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s13054-018-2144-4","article-title":"Refractory septic shock: our pragmatic approach","volume":"22","author":"Nandhabalan","year":"2018","journal-title":"Crit Care"},{"issue":"17","key":"10.1016\/j.redare.2026.502116_bib0025","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa1312173","article-title":"High versus low blood-pressure target in patients with septic shock","volume":"370","author":"Asfar","year":"2014","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.redare.2026.502116_bib0030","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/CCM.0000000000005344","article-title":"Early multimodal vasopressors\u2014are we ready for it?*","volume":"50","author":"Wieruszewski","year":"2022","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.redare.2026.502116_bib0035","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13054-022-03911-7","article-title":"Vasopressor choice and timing in vasodilatory shock","volume":"26","author":"Wieruszewski","year":"2022","journal-title":"Crit Care"},{"issue":"5","key":"10.1016\/j.redare.2026.502116_bib0040","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.redare.2026.502116_bib0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/ALN.0000000000005633","article-title":"Modulation of the renin\u2013angiotensin system in critically ill patients: addressing seven key questions for the intensivist","volume":"144","author":"Calabrese","year":"2025","journal-title":"Anesthesiology"},{"issue":"5","key":"10.1016\/j.redare.2026.502116_bib0050","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1161\/HYPERTENSIONAHA.123.21364","article-title":"Alternative renin-angiotensin system","volume":"81","author":"Bader","year":"2024","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.redare.2026.502116_bib0055","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1152\/advan.00049.2009","article-title":"The renal renin-angiotensin system","volume":"33","author":"Harrison-Bernard","year":"2009","journal-title":"Adv Physiol Educ"},{"issue":"1","key":"10.1016\/j.redare.2026.502116_bib0060","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1186\/s13054-023-04739-5","article-title":"The alternative renin\u2013angiotensin system in critically ill patients: pathophysiology and therapeutic implications","volume":"27","author":"Garcia","year":"2023","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.redare.2026.502116_bib0065","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s13054-024-05123-7","article-title":"The renin\u2013angiotensin\u2013aldosterone-system in sepsis and its clinical modulation with exogenous angiotensin II","volume":"28","author":"Legrand","year":"2024","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.redare.2026.502116_bib0070","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13613-025-01463-x","article-title":"Alterations in the renin-angiotensin system during septic shock","volume":"15","author":"Benaroua","year":"2025","journal-title":"Ann Intensive Care"},{"issue":"3","key":"10.1016\/j.redare.2026.502116_bib0075","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/jbcr\/irae208","article-title":"Vasoactive agents in burn patients: perspectives on angiotensin-II","volume":"46","author":"Mueller","year":"2025","journal-title":"J Burn Care Res"},{"issue":"3","key":"10.1016\/j.redare.2026.502116_bib0080","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/phar.2220","article-title":"Vasoactive agent use in septic shock: beyond first\u2010line recommendations","volume":"39","author":"Sacha","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.redare.2026.502116_bib0085","unstructured":"Anexo 1: Ficha t\u00e9cnica o resumen de las caracter\u00edsticas del producto [accessed 16 Dec 2025]. Available from: https:\/\/www.ema.europa.eu\/es\/documents\/product-information\/giapreza-epar-product-information_es.pdf."},{"key":"10.1016\/j.redare.2026.502116_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2023.154453","article-title":"Exploring the norepinephrine to angiotensin II conversion ratio in patients with vasodilatory hypotension: a post-hoc analysis of the ARAMIS trial","volume":"79","author":"See","year":"2024","journal-title":"J Crit Care"},{"issue":"1","key":"10.1016\/j.redare.2026.502116_bib0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13054-023-04322-y","article-title":"An updated \u201cnorepinephrine equivalent\u201d score in intensive care as a marker of shock severity","volume":"27","author":"Kotani","year":"2023","journal-title":"Crit Care"},{"issue":"9","key":"10.1016\/j.redare.2026.502116_bib0100","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.201911-2172OC","article-title":"Renin and survival in patients given angiotensin II for catecholamine-resistant vasodilatory shock. A clinical trial","volume":"202","author":"Bellomo","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.redare.2026.502116_bib0105","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/CCM.0000000000003092","article-title":"Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II","volume":"46","author":"Tumlin","year":"2018","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.redare.2026.502116_bib0110","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1161\/HYPERTENSIONAHA.110.158220","article-title":"Angiotensin II\u2013mediated microvascular thrombosis","volume":"56","author":"Senchenkova","year":"2010","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.redare.2026.502116_bib0115","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1053\/j.jvca.2024.12.022","article-title":"The efficacy and safety of angiotensin II for treatment of vasoplegia in critically ill patients: a systematic review","volume":"39","author":"Kotani","year":"2025","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"6","key":"10.1016\/j.redare.2026.502116_bib0120","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.ajem.2019.03.026","article-title":"Angiotensin II in septic shock","volume":"37","author":"Jadhav","year":"2019","journal-title":"Am J Emerg Med"},{"issue":"4","key":"10.1016\/j.redare.2026.502116_bib0125","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/CCM.0000000000006176","article-title":"Position paper on the reporting of norepinephrine formulations in critical care from the Society of Critical Care Medicine and European Society of Intensive Care Medicine Joint Task Force","volume":"52","author":"Wieruszewski","year":"2024","journal-title":"Crit Care Med"},{"issue":"3","key":"10.1016\/j.redare.2026.502116_bib0130","article-title":"Multimodal strategy to counteract vasodilation in septic shock","volume":"42","author":"Leone","year":"2023","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"1","key":"10.1016\/j.redare.2026.502116_bib0135","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13054-023-04446-1","article-title":"Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial","volume":"27","author":"Wieruszewski","year":"2023","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.redare.2026.502116_bib0140","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s13054-021-03725-z","article-title":"Serum renin and major adverse kidney events in critically ill patients: a multicenter prospective study","volume":"25","author":"Flannery","year":"2021","journal-title":"Crit Care"},{"issue":"10","key":"10.1016\/j.redare.2026.502116_bib0145","doi-asserted-by":"crossref","first-page":"R1226","DOI":"10.1152\/ajpregu.00228.2015","article-title":"Variable responses of regional renal oxygenation and perfusion to vasoactive agents in awake sheep","volume":"309","author":"Calzavacca","year":"2015","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"5","key":"10.1016\/j.redare.2026.502116_bib0150","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1053\/j.jvca.2025.01.042","article-title":"Evaluation of angiotensin II in patients with catecholamine-resistant vasodilatory shock requiring continuous renal replacement therapy (ANGEL CRRT)","volume":"39","author":"Rettele","year":"2025","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.redare.2026.502116_bib0155","first-page":"88","article-title":"Angiotensin II for catecholamine resistant vasodilatory shock in patients with acute kidney injury: a post-hoc analysis of the ATHOS-3 trial","volume":"63","author":"Chaba","year":"2024","journal-title":"Shock"},{"issue":"6","key":"10.1016\/j.redare.2026.502116_bib0160","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1378\/chest.95.6.1282","article-title":"Effect of dopamine vs norepinephrine on hemodynamics in septic shock","volume":"95","author":"Schreuder","year":"1989","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.redare.2026.502116_bib0165","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13613-023-01227-5","article-title":"Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shock","volume":"13","author":"Leisman","year":"2023","journal-title":"Ann Intensive Care"},{"issue":"1","key":"10.1016\/j.redare.2026.502116_bib0170","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13054-024-04910-6","article-title":"ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shock","volume":"28","author":"Leisman","year":"2024","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.redare.2026.502116_bib0175","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.3390\/biomedicines13061442","article-title":"Angiotensin receptor blockade does not decrease synthetic angiotensin II (Giapreza\u00ae) effectiveness in perioperative hypotension surrounding kidney transplant","volume":"13","author":"Pettit","year":"2025","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.redare.2026.502116_bib0180","first-page":"e0623","article-title":"Effectiveness of angiotensin II for catecholamine refractory septic or distributive shock on mortality: a propensity score weighted analysis of real-world experience in the medical ICU","volume":"4","author":"Quan","year":"2022","journal-title":"Crit Care Explor"},{"issue":"1","key":"10.1016\/j.redare.2026.502116_bib0185","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13054-025-05311-z","article-title":"An index of the initial blood pressure response to angiotensin II treatment and its association with clinical outcomes in vasodilatory shock","volume":"29","author":"Leisman","year":"2025","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.redare.2026.502116_bib0190","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2217\/fca-2020-0019","article-title":"Roles of angiotensin II as vasopressor in vasodilatory shock","volume":"16","author":"Lumlertgul","year":"2020","journal-title":"Future Cardiol"},{"issue":"1","key":"10.1016\/j.redare.2026.502116_bib0195","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/s13054-022-04255-y","article-title":"A plea for personalization of the hemodynamic management of septic shock","volume":"26","author":"De Backer","year":"2022","journal-title":"Crit Care"},{"issue":"11","key":"10.1016\/j.redare.2026.502116_bib0200","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.3390\/jpm13111548","article-title":"Vasopressin in sepsis and other shock states: state of the art","volume":"13","author":"Garc\u00eda-\u00c1lvarez","year":"2023","journal-title":"JPM"},{"issue":"2","key":"10.1016\/j.redare.2026.502116_bib0205","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3390\/jpm14020176","article-title":"Challenges in septic shock: from new hemodynamics to blood purification therapies","volume":"14","author":"Ramasco","year":"2024","journal-title":"JPM"},{"issue":"1","key":"10.1016\/j.redare.2026.502116_bib0210","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/CCM.0000000000005143","article-title":"Renin kinetics are superior to lactate kinetics for predicting in-hospital mortality in hypotensive critically ill patients","volume":"50","author":"Jeyaraju","year":"2022","journal-title":"Criti Care Med"},{"issue":"8","key":"10.1016\/j.redare.2026.502116_bib0215","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.3390\/biomedicines12081817","article-title":"Angiotensin II as a vasopressor for perioperative hypotension in solid organ transplant","volume":"12","author":"Benken","year":"2024","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.redare.2026.502116_bib0220","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13054-020-2733-x","article-title":"Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock","volume":"24","author":"Bellomo","year":"2020","journal-title":"Crit Care"},{"issue":"1","key":"10.1016\/j.redare.2026.502116_bib0225","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40635-024-00638-3","article-title":"Inhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injury","volume":"12","author":"Garcia","year":"2024","journal-title":"ICMx"},{"issue":"4","key":"10.1016\/j.redare.2026.502116_bib0230","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1161\/HYPERTENSIONAHA.123.21913","article-title":"Circulating dipeptidyl peptidase 3 modulates systemic and renal hemodynamics through cleavage of angiotensin peptides","volume":"81","author":"Picod","year":"2024","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.redare.2026.502116_bib0235","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13054-020-2743-8","article-title":"Vasoplegic syndrome following cardiothoracic surgery\u2014review of pathophysiology and update of treatment options","volume":"24","author":"Busse","year":"2020","journal-title":"Crit Care"},{"issue":"9","key":"10.1016\/j.redare.2026.502116_bib0240","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/anae.15802","article-title":"A double\u2010blind randomised feasibility trial of angiotensin\u20102 in cardiac surgery","volume":"77","author":"Coulson","year":"2022","journal-title":"Anaesthesia"},{"key":"10.1016\/j.redare.2026.502116_bib0245","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.xjon.2025.04.014","article-title":"Association between timing of angiotensin II administration and outcomes in vasoplegia after cardiac surgery","volume":"25","author":"Miles","year":"2025","journal-title":"JTCVS Open"},{"issue":"2","key":"10.1016\/j.redare.2026.502116_bib0250","article-title":"Intraoperative use of angiotensin II for severe vasodilatory shock during liver transplantation: a case report","volume":"15","author":"Running","year":"2021","journal-title":"A&A Pract"}],"container-title":["Revista Espa\u00f1ola de Anestesiolog\u00eda y Reanimaci\u00f3n (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341192926001010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2341192926001010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T12:25:08Z","timestamp":1779107108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2341192926001010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2341192926001010"],"URL":"https:\/\/doi.org\/10.1016\/j.redare.2026.502116","relation":{},"ISSN":["2341-1929"],"issn-type":[{"value":"2341-1929","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin II in the treatment of distributive shock and identification of clinical profiles with greater therapeutic benefit","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Anestesiolog\u00eda y Reanimaci\u00f3n (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.redare.2026.502116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.redar.2026.502116","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Anestesiolog\u00eda, Reanimaci\u00f3n y Terap\u00e9utica del Dolor.","name":"copyright","label":"Copyright"}],"article-number":"502116"}}